Unlock instant, AI-driven research and patent intelligence for your innovation.

New use of baicalin as medicine for treating anxiety neurosis

A new technology of baicalin, which is applied in the field of preparation of drugs for treating various anxiety diseases, can solve problems such as unseen treatments, and achieve the effect of avoiding central nervous system inhibition

Inactive Publication Date: 2004-11-24
PHARMACOGENETICS
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinically, there are no drugs and preparations containing baicalin as the main medicinal raw material for the treatment, control and relief of various anxiety symptoms.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New use of baicalin as medicine for treating anxiety neurosis
  • New use of baicalin as medicine for treating anxiety neurosis
  • New use of baicalin as medicine for treating anxiety neurosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029] 1. γ-aminobutyric acid receptor (GABA) competitive binding baicalin assay results:

[0030] The radioimmunocompetitive binding method was used to determine the 50% stable binding concentration of compound baicalin in GABA receptor competitive inhibition (IC 50 ) and the competitive inhibition stable binding constant (K i ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
weightaaaaaaaaaa
Login to View More

Abstract

The present invention reveals the new medicinal use of baicalin as the effective medicinal components in skullcap root and stem and proposes the application of baicalin compound in treating various anxiety neurosis. It is proved that baicalin taken by mouse in the dosage of 7.5-30 mg / kg has obvious and reliable effect of resisting anxiety neurosis, so that the orally taken dosage for human is calculated to be 0.8-3.5 mg / kg. Baicalin is extracted from skullcap root and stem, has purity not lower than 97 %, and may be prepared into tablet, capsule, dripping pill, oral liquid, injection, etc. The present invention has outstand medicinal effect, low toxicity and low cost.

Description

technical field [0001] The invention relates to a new application of baicalin, an effective medicinal component in the rhizome of the Chinese herbal medicine Scutellaria baicalensis, for preparing medicines for treating various anxiety diseases. Background technique [0002] According to traditional Chinese medicine, Scutellaria baicalensis Georgi is the dry root of Labiatae plants. Cold in nature, bitter in taste, returns to lung; gallbladder; spleen; large intestine and small intestine meridians. Its medicinal functions are clearing away heat and dampness; purging fire and detoxifying; stopping bleeding; antiabortive. Traditional Chinese medicine is mostly used for damp heat, summer heat, chest tightness and nausea, damp heat and fullness, diarrhea and jaundice, cough due to lung heat, high fever and polydipsia, vomiting of blood heat at the nose, carbuncle sores and fetal restlessness. (Chinese Pharmacopoeia, the first 1995, pp.270) modern medical research proves: the m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K36/539A61P25/22C07D311/30
CPCA61K36/539A61P25/22
Inventor 薛红郑辉王子晖
Owner PHARMACOGENETICS